Abnormal function and thromboxane release from platelets of dogs with cyclic hematopoiesis

Area of Science:

• Hematology
• Canine Medicine
• Platelet Physiology

Background:

• Cyclic hematopoiesis (CH) in dogs is characterized by cyclical neutropenia.
• Platelet function in CH dogs has not been thoroughly investigated.
• Understanding platelet behavior is crucial for diagnosing and managing hematological disorders.

Purpose of the Study:

• To investigate platelet function in dogs with cyclic hematopoiesis (CH).
• To determine if CH affects platelet aggregation.
• To explore the potential of platelet defects as a genetic marker for CH.

Main Methods:

• Assessed collagen-induced and ADP-induced platelet aggregation in CH dogs.
• Measured thromboxane-B2 levels in platelets.
• Compared platelet function between CH dogs, heterozygous CH dogs, and normal dogs.

Main Results:

• CH dog platelets exhibited significantly abnormal collagen-induced aggregation.
• Platelet aggregation defects were most pronounced during specific phases of the neutrophil cycle.
• Thromboxane-B2 levels were significantly reduced in CH dog platelets.
• Heterozygous CH dogs showed intermediate platelet aggregation responses.

Conclusions:

• Dogs with CH have a distinct platelet aggregation disorder.
• The defect appears linked to the arachidonic acid pathway.
• Platelet function abnormalities can serve as a potential genetic marker for identifying heterozygous CH dogs.